Literature DB >> 21554524

Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.

J Grierson1, R L Koelmeyer, A Smith, M Pitts.   

Abstract

OBJECTIVES: Given the importance of adherence to combination antiretroviral therapy (cART) for the reduced morbidity and improved mortality of people living with HIV infection (PLWH), we set out to determine which of a number of previously investigated personal, socioeconomic, treatment-related and disease-related factors were independently associated with self-reported difficulty taking antiretroviral therapy (ART) in an Australian sample of PLWH.
METHODS: Using data from a national cross-sectional survey of 1106 PLWH, we conducted bivariate and multivariable analyses to assess the association of over 70 previously investigated factors with self-reported difficulty taking ART. Factors that maintained an association with reported difficulty taking ART at the level of α=0.05 in the multivariable logistic regression analysis were considered to be independently associated with reported difficulty taking ART.
RESULTS: A total of 867 (78.4%) survey respondents were taking antiretroviral medication at the time of completing the HIV Futures 6 survey. Overall, 39.1% of these respondents reported difficulty taking ART. Factors found to be independently associated with reported difficulty taking ART included younger age, alcohol and party drug use, poor or fair self-reported health, diagnosis of a mental health condition, living in a regional centre, taking more than one ART dose per day, experiencing physical adverse events or health service discrimination, certain types of ART regimen and specific attitudes towards ART and HIV.
CONCLUSIONS: Thirteen previously investigated factors were found to be independently associated with reported difficulty taking ART, reaffirming the dynamic nature of adherence behaviour and the ongoing importance of addressing adherence behaviour in the clinical management of PLWH.
© 2011 British HIV Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21554524     DOI: 10.1111/j.1468-1293.2011.00928.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  21 in total

1.  Operationalizing treatment as prevention in Los Angeles County: antiretroviral therapy use and factors associated with unsuppressed viral load in the Ryan White system of care.

Authors:  Jennifer N Sayles; Jacqueline Rurangirwa; Min Kim; Janni Kinsler; Rangell Oruga; Mike Janson
Journal:  AIDS Patient Care STDS       Date:  2012-07-09       Impact factor: 5.078

Review 2.  Interventions to reduce alcohol use among HIV-infected individuals: a review and critique of the literature.

Authors:  Jennifer L Brown; Kelly S DeMartini; Jessica M Sales; Andrea L Swartzendruber; Ralph J DiClemente
Journal:  Curr HIV/AIDS Rep       Date:  2013-12       Impact factor: 5.071

3.  Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection.

Authors:  Peng Xiao; Sanjeev Gumber; Mark A Marzinke; Abhijit A Date; Thuy Hoang; Justin Hanes; Laura M Ensign; Lin Wang; Lisa Rohan; Edward J Fuchs; Craig Hendrix; Francois Villinger
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

4.  Chronic binge alcohol consumption does not diminish effectiveness of continuous antiretroviral suppression of viral load in simian immunodeficiency virus-infected macaques.

Authors:  Patricia E Molina; Angela M Amedee; Ron Veazey; Jason Dufour; Julia Volaufova; Gregory J Bagby; Steve Nelson
Journal:  Alcohol Clin Exp Res       Date:  2014-09       Impact factor: 3.455

Review 5.  Comprehensive clinical care for men who have sex with men: an integrated approach.

Authors:  Kenneth H Mayer; Linda-Gail Bekker; Ron Stall; Andrew E Grulich; Grant Colfax; Javier R Lama
Journal:  Lancet       Date:  2012-07-20       Impact factor: 79.321

6.  Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy.

Authors:  Maged M Costantine; Ilan Matok; Guisseppe Chiossi; Shannon Clark; Menachem Miodovnik; Jason G Umans; Steve Caritis; Gary D V Hankins; Gideon Koren
Journal:  Ther Drug Monit       Date:  2012-10       Impact factor: 3.681

7.  Simian Immunodeficiency Virus Infection Increases Blood Ethanol Concentration Duration After Both Acute and Chronic Administration.

Authors:  Liz Simon; Robert Siggins; Peter Winsauer; Meghan Brashear; Tekeda Ferguson; Don Mercante; Kejing Song; Curtis Vande Stouwe; Steve Nelson; Gregory Bagby; Angela Amedee; Patricia E Molina
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11-21       Impact factor: 2.205

8.  Impacts of HIV Stigma on Psychosocial Well-Being and Substance Use Behaviors Among People Living With HIV/AIDS In China: Across the Life Span.

Authors:  Chen Zhang; Xiaoming Li; Yu Liu; Yuejiao Zhou; Zhiyong Shen; Yi Chen
Journal:  AIDS Educ Prev       Date:  2018-04

9.  A family history of substance dependence obscures the group differences in brain function associated with HIV-1 and ART.

Authors:  L O Bauer
Journal:  Drug Alcohol Depend       Date:  2012-06-29       Impact factor: 4.492

10.  Socially-integrated transdisciplinary HIV prevention.

Authors:  Samuel R Friedman; Martin J Downing; Pavlo Smyrnov; Georgios Nikolopoulos; John A Schneider; Britt Livak; Gkikas Magiorkinis; Liudmyla Slobodianyk; Tetyana I Vasylyeva; Dimitrios Paraskevis; Mina Psichogiou; Vana Sypsa; Melpomeni M Malliori; Angelos Hatzakis
Journal:  AIDS Behav       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.